Does CEMIPLIMAB-RWLC Cause Immune-mediated enterocolitis? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Immune-mediated enterocolitis have been filed in association with CEMIPLIMAB-RWLC. This represents 0.6% of all adverse event reports for CEMIPLIMAB-RWLC.
10
Reports of Immune-mediated enterocolitis with CEMIPLIMAB-RWLC
0.6%
of all CEMIPLIMAB-RWLC reports
3
Deaths
6
Hospitalizations
How Dangerous Is Immune-mediated enterocolitis From CEMIPLIMAB-RWLC?
Of the 10 reports, 3 (30.0%) resulted in death, 6 (60.0%) required hospitalization, and 1 (10.0%) were considered life-threatening.
Is Immune-mediated enterocolitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CEMIPLIMAB-RWLC. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does CEMIPLIMAB-RWLC Cause?
Death (128)
Disease progression (101)
Fatigue (71)
Off label use (68)
Rash (64)
Dyspnoea (55)
Pyrexia (52)
Pruritus (44)
Asthenia (42)
Diarrhoea (42)
What Other Drugs Cause Immune-mediated enterocolitis?
NIVOLUMAB (1,289)
IPILIMUMAB (988)
PEMBROLIZUMAB (858)
CARBOPLATIN (307)
PACLITAXEL (188)
DURVALUMAB (165)
ATEZOLIZUMAB (156)
LENVATINIB (143)
PEMETREXED (129)
BEVACIZUMAB (92)
Which CEMIPLIMAB-RWLC Alternatives Have Lower Immune-mediated enterocolitis Risk?
CEMIPLIMAB-RWLC vs CENEGERMIN-BKBJ
CEMIPLIMAB-RWLC vs CENOBAMATE
CEMIPLIMAB-RWLC vs CEPHALEXIN
CEMIPLIMAB-RWLC vs CERITINIB
CEMIPLIMAB-RWLC vs CERLIPONASE ALFA